Scintigraphic control of radioiodine 131-I distribution following administration of therapeutic dose for a differentiated cancer of the thyroid gland.
作者信息
Röhling S, Nĕmec J, Zamrazil V, Pohunková D, Jezek V
出版信息
Czech Med. 1983;6(2):125-6.
PMID:6409563
Abstract
摘要
相似文献
1
2
Radioiodine in treatment of metastatic thyroid cancer.
Int J Nucl Med Biol. 1979;6(4):213-4. doi: 10.1016/0047-0740(79)90042-1.
3
[Parotid gland function following radioiodine therapy of thyroid cancer based on data from radionuclide sialoscintigraphy].[基于放射性核素唾液腺闪烁扫描数据的甲状腺癌放射性碘治疗后的腮腺功能]
Stomatologiia (Mosk). 1987 Mar-Apr;66(2):50-2.
4
[Stunning effects in radioiodine therapy of thyroid carcinoma: existence, clinical effects and ways out].[甲状腺癌放射性碘治疗中的“顿抑”效应：存在情况、临床影响及解决办法]
Nuklearmedizin. 2003 Feb;42(1):10-4.
5
Stunning after tracer dosimetry.
J Nucl Med. 2001 Jul;42(7):1129.
6
A Case of Radioactive Iodine Uptake Found in Artificial Eye.人工眼球中发现放射性碘摄取病例。
Clin Nucl Med. 2019 Apr;44(4):317-318. doi: 10.1097/RLU.0000000000002486.
7
8
Postoperative uptake in the thyroid bed, not tumor stage, determines the usefulness of diagnostic whole body scan in the first year after ablation with radioiodine.
Thyroid. 2007 Aug;17(8):803-4. doi: 10.1089/thy.2007.0138.
9
[The autonomous thyroid nodule: results of treatment with radioiodine].
Rev Med Chil. 1986 Mar;114(3):228-31.
10
Radioiodine and thyroid cancer: some questions, controversies, and considerations.
Endocr Pract. 2001 Jul-Aug;7(4):320-3. doi: 10.4158/EP.7.4.320.
Zotero 插件